Loading...
XSHE002412
Market cap402mUSD
Jan 09, Last price  
5.81CNY
1D
0.34%
1Q
-1.51%
Jan 2017
-45.09%
IPO
-1.84%
Name

Hunan Hansen Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002412 chart
P/E
14.26
P/S
3.06
EPS
0.41
Div Yield, %
5.16%
Shrs. gr., 5y
—
Rev. gr., 5y
0.72%
Revenues
956m
+4.31%
126,746,714166,938,502235,689,232283,211,383343,415,468400,786,021489,461,123584,932,130737,424,613781,127,866798,466,937829,937,833921,949,823887,490,963741,237,325891,835,182916,062,371955,530,797
Net income
205m
+22.31%
11,248,32737,874,14342,494,73749,250,24462,021,15158,827,03681,459,377110,832,646111,800,11692,656,27871,491,76998,142,066140,763,907159,695,917106,146,369134,848,862167,615,535205,014,883
CFO
161m
+11.92%
037,751,61333,938,73841,017,07121,240,66353,840,759100,226,72076,091,51285,045,38963,574,403161,156,078107,177,232217,517,355165,106,317162,185,165212,536,478143,806,247160,946,070
Dividend
Jun 20, 20230.3 CNY/sh
Earnings
May 21, 2025

Profile

Hunan Hansen Pharmaceutical Co., Ltd. produces and sells Chinese and chemical medicine preparations in China and internationally. It provides medicines in injection, oral liquid, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. The company is based in Yiyang, China.
URL
http://www.hansenzy.com
IPO date
May 25, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
955,531
4.31%
916,062
2.72%
Cost of revenue
623,808
718,079
Unusual Expense (Income)
NOPBT
331,723
197,984
NOPBT Margin
34.72%
21.61%
Operating Taxes
21,002
14,237
Tax Rate
6.33%
7.19%
NOPAT
310,721
183,747
Net income
205,015
22.31%
167,616
24.30%
Dividends
(150,960)
Dividend yield
4.42%
Proceeds from repurchase of equity
1,350
BB yield
-0.04%
Debt
Debt current
95,120
120,150
Long-term debt
Deferred revenue
16,810
15,032
Other long-term liabilities
Net debt
(1,001,688)
(806,605)
Cash flow
Cash from operating activities
160,946
143,806
CAPEX
(19,475)
Cash from investing activities
(82,889)
Cash from financing activities
(179,670)
FCF
168,058
68,012
Balance
Cash
255,001
281,227
Long term investments
841,807
645,528
Excess cash
1,049,032
880,952
Stockholders' equity
1,730,263
1,661,365
Invested Capital
1,025,928
1,132,391
ROIC
28.79%
16.26%
ROCE
15.98%
9.83%
EV
Common stock shares outstanding
503,200
503,200
Price
6.78
10.60%
6.13
-3.46%
Market cap
3,411,696
10.60%
3,084,616
-3.46%
EV
2,410,008
2,278,011
EBITDA
383,407
249,572
EV/EBITDA
6.29
9.13
Interest
3,894
3,905
Interest/NOPBT
1.17%
1.97%